J. Safra Sarasin Holding AG Sells 39,952 Shares of Agilent Technologies, Inc. $A

J. Safra Sarasin Holding AG reduced its position in shares of Agilent Technologies, Inc. (NYSE:A) by 18.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 180,319 shares of the medical research company’s stock after selling 39,952 shares during the quarter. J. Safra Sarasin Holding AG’s holdings in Agilent Technologies were worth $24,536,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also made changes to their positions in A. Norges Bank bought a new position in shares of Agilent Technologies during the 2nd quarter worth $395,088,000. AQR Capital Management LLC raised its holdings in shares of Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after acquiring an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Agilent Technologies by 132.2% in the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after acquiring an additional 1,340,161 shares in the last quarter. Troy Asset Management Ltd lifted its stake in Agilent Technologies by 74.3% in the second quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock worth $282,967,000 after acquiring an additional 1,021,865 shares during the period. Finally, Ilex Capital Partners UK LLP bought a new position in Agilent Technologies during the 2nd quarter worth about $96,684,000.

Agilent Technologies Stock Up 1.6%

NYSE:A opened at $111.99 on Tuesday. The company’s 50-day simple moving average is $123.07 and its 200-day simple moving average is $134.85. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The stock has a market capitalization of $31.65 billion, a P/E ratio of 24.72, a P/E/G ratio of 2.32 and a beta of 1.31.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter last year, the firm earned $1.31 EPS. The company’s revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is currently 22.52%.

Analysts Set New Price Targets

A has been the topic of a number of research reports. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and raised their target price for the company from $155.00 to $160.00 in a research report on Monday, January 5th. Barclays dropped their price objective on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. HSBC began coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price objective on the stock. UBS Group lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Finally, The Goldman Sachs Group initiated coverage on Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 target price on the stock. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.